Liza Marie Quintana, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Biology | 1 | 2021 | 91 | 0.710 |
Why?
|
| Phyllodes Tumor | 3 | 2021 | 54 | 0.530 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2023 | 920 | 0.520 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2024 | 1758 | 0.410 |
Why?
|
| Breast Neoplasms | 11 | 2023 | 21056 | 0.390 |
Why?
|
| Pancreatic Neoplasms | 1 | 2024 | 5444 | 0.260 |
Why?
|
| Ribosomes | 1 | 2024 | 493 | 0.180 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2024 | 1133 | 0.180 |
Why?
|
| DNA Transposable Elements | 1 | 2024 | 765 | 0.180 |
Why?
|
| Microscopy, Ultraviolet | 1 | 2018 | 3 | 0.150 |
Why?
|
| Lymph Nodes | 2 | 2020 | 3454 | 0.150 |
Why?
|
| Papilloma | 1 | 2018 | 141 | 0.140 |
Why?
|
| Cicatrix | 1 | 2023 | 798 | 0.140 |
Why?
|
| Breast | 2 | 2023 | 1946 | 0.140 |
Why?
|
| Cartilage | 1 | 2019 | 798 | 0.120 |
Why?
|
| Mammography | 2 | 2023 | 2423 | 0.120 |
Why?
|
| Biopsy | 2 | 2023 | 6763 | 0.110 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 11083 | 0.110 |
Why?
|
| Lymph Node Excision | 1 | 2019 | 1259 | 0.100 |
Why?
|
| Nurses | 1 | 2022 | 2505 | 0.100 |
Why?
|
| Immunohistochemistry | 3 | 2018 | 11022 | 0.080 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 1275 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2024 | 8611 | 0.080 |
Why?
|
| Mediastinum | 2 | 2020 | 271 | 0.070 |
Why?
|
| Prostatectomy | 1 | 2016 | 1782 | 0.070 |
Why?
|
| Reference Standards | 2 | 2021 | 1013 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2024 | 6364 | 0.070 |
Why?
|
| Female | 14 | 2024 | 396112 | 0.060 |
Why?
|
| Humans | 18 | 2024 | 765968 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2020 | 3458 | 0.060 |
Why?
|
| Research Design | 1 | 2020 | 6209 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2018 | 8923 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2024 | 59489 | 0.050 |
Why?
|
| Vitamin D | 1 | 2016 | 3272 | 0.050 |
Why?
|
| Ribosomal Proteins | 1 | 2024 | 366 | 0.050 |
Why?
|
| Aged | 5 | 2024 | 171117 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9525 | 0.040 |
Why?
|
| Predictive Value of Tests | 3 | 2022 | 15398 | 0.040 |
Why?
|
| Middle Aged | 5 | 2024 | 223009 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 5849 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 904 | 0.040 |
Why?
|
| Histological Techniques | 1 | 2018 | 193 | 0.040 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2022 | 1119 | 0.030 |
Why?
|
| Retinoid X Receptors | 1 | 2016 | 91 | 0.030 |
Why?
|
| Ultrasonography, Mammary | 1 | 2018 | 241 | 0.030 |
Why?
|
| Radioimmunoassay | 1 | 2016 | 860 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 13451 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2021 | 1329 | 0.030 |
Why?
|
| Needles | 1 | 2018 | 460 | 0.030 |
Why?
|
| Workflow | 1 | 2020 | 862 | 0.030 |
Why?
|
| Adult | 4 | 2024 | 223044 | 0.030 |
Why?
|
| Endosonography | 1 | 2019 | 626 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 545 | 0.030 |
Why?
|
| Mastectomy, Segmental | 1 | 2019 | 964 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2022 | 2242 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2019 | 81514 | 0.030 |
Why?
|
| Receptors, Calcitriol | 1 | 2016 | 361 | 0.030 |
Why?
|
| Male | 3 | 2024 | 363698 | 0.030 |
Why?
|
| International Cooperation | 1 | 2020 | 1432 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2024 | 2968 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2020 | 1509 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 2878 | 0.030 |
Why?
|
| Fibrosis | 1 | 2020 | 2070 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2021 | 9373 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2022 | 2858 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 1531 | 0.020 |
Why?
|
| Equipment Design | 1 | 2018 | 3481 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2024 | 10429 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3797 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 17075 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2022 | 14652 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 12976 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2020 | 8067 | 0.010 |
Why?
|
| Young Adult | 2 | 2019 | 59889 | 0.010 |
Why?
|
| Logistic Models | 1 | 2016 | 13266 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41649 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2016 | 22223 | 0.010 |
Why?
|
| Mice | 1 | 2024 | 81819 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39193 | 0.010 |
Why?
|
| Animals | 1 | 2024 | 168764 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 54802 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 74840 | 0.000 |
Why?
|
| Neoplasms | 1 | 2017 | 22340 | 0.000 |
Why?
|